173 related articles for article (PubMed ID: 38274229)
1. Potential disease biomarkers for diabetic retinopathy identified through Mendelian randomization analysis.
Zou X; Ye S; Tan Y
Front Endocrinol (Lausanne); 2023; 14():1339374. PubMed ID: 38274229
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease as a causal risk factor for diabetic retinopathy: a Mendelian randomization study.
Ouyang F; Yuan P; Ju Y; Chen W; Peng Z; Xu H
Front Endocrinol (Lausanne); 2024; 15():1340608. PubMed ID: 38699385
[TBL] [Abstract][Full Text] [Related]
3. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
Yuan W; Xu W; Xu X; Qu B; Zhao F
Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
[TBL] [Abstract][Full Text] [Related]
4. The causal effect of obesity on diabetic retinopathy: A two-sample Mendelian randomization study.
Zheng C; Wei X; Cao X
Front Endocrinol (Lausanne); 2023; 14():1108731. PubMed ID: 37077358
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the association between genetic factors regulating thyroid function and microvascular complications in diabetes: A two-sample Mendelian randomization study in the European population.
Li H; Li M; Dong S; Zhang S; Dong A; Zhang M
Front Endocrinol (Lausanne); 2023; 14():1126339. PubMed ID: 36926020
[TBL] [Abstract][Full Text] [Related]
6. Diabetic retinopathy risk in patients with unhealthy lifestyle: A Mendelian randomization study.
Su Z; Wu Z; Liang X; Xie M; Xie J; Li H; Wang X; Jiang F
Front Endocrinol (Lausanne); 2022; 13():1087965. PubMed ID: 36733810
[TBL] [Abstract][Full Text] [Related]
7. Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.
Li N; Zhang X; Zhang M; Wu L; Li C; Pan Y; Wang W; Ji J; Zheng D
Atherosclerosis; 2023 Mar; 369():9-16. PubMed ID: 36827905
[TBL] [Abstract][Full Text] [Related]
8. Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study.
Chen C; Zhang H; Lan Y; Yan W; Liu S; Chen Y; Xie T; Ning J; Yan X; Shang L; Han J
J Transl Med; 2024 Mar; 22(1):298. PubMed ID: 38520016
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammatory regulators and proliferative diabetic retinopathy: A bidirectional Mendelian randomization study.
Shi Q; Wang Q; Wang Z; Lu J; Wang R
Front Immunol; 2023; 14():1088778. PubMed ID: 36845092
[TBL] [Abstract][Full Text] [Related]
10. Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization study.
Fang J; Luo C; Zhang D; He Q; Liu L
Front Endocrinol (Lausanne); 2023; 14():1265711. PubMed ID: 38027162
[TBL] [Abstract][Full Text] [Related]
11. Mendelian randomization analysis reveals a causal effect of Streptococcus salivarius on diabetic retinopathy through regulating host fasting glucose.
Li J; Zheng G; Jiang D; Deng C; Zhang Y; Ma Y; Su J
J Cell Mol Med; 2024 Apr; 28(7):e18200. PubMed ID: 38506069
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies.
Zheng D; Li N; Hou R; Zhang X; Wu L; Sundquist J; Sundquist K; Ji J
BMC Med; 2023 Feb; 21(1):40. PubMed ID: 36737746
[TBL] [Abstract][Full Text] [Related]
13. Mendelian Randomization Analysis Reveals Causal Effects of Polyunsaturated Fatty Acids on Subtypes of Diabetic Retinopathy Risk.
Ren S; Xue C; Xu M; Li X
Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836492
[TBL] [Abstract][Full Text] [Related]
14. The causal effect of hypertension, intraocular pressure, and diabetic retinopathy: a Mendelian randomization study.
Wang XF; Zhang XW; Liu YJ; Zheng XY; Su MR; Sun XH; Jiang F; Liu ZN
Front Endocrinol (Lausanne); 2024; 15():1304512. PubMed ID: 38379860
[TBL] [Abstract][Full Text] [Related]
15. Diabetic Retinopathy and Brain Structure, Cognition Function, and Dementia: A Bidirectional Mendelian Randomization Study.
Chai YH; Han YP; Zhang JY; Zhou JB
J Alzheimers Dis; 2024; 97(3):1211-1221. PubMed ID: 38217603
[TBL] [Abstract][Full Text] [Related]
16. Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study.
Liu K; Zou J; Fan H; Hu H; You Z
Front Immunol; 2022; 13():930318. PubMed ID: 36159877
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of Mendelian randomization and gene expression profiles reveals a null causal relationship between adiponectin and diabetic retinopathy.
Zhang A; Wu H; Wang C; Tian S
Adipocyte; 2023 Dec; 12(1):2234522. PubMed ID: 37459460
[TBL] [Abstract][Full Text] [Related]
18. Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes.
Skol AD; Jung SC; Sokovic AM; Chen S; Fazal S; Sosina O; Borkar PP; Lin A; Sverdlov M; Cao D; Swaroop A; Bebu I; ; Stranger BE; Grassi MA
Elife; 2020 Nov; 9():. PubMed ID: 33164750
[TBL] [Abstract][Full Text] [Related]
19. Relationship between circulating metabolites and diabetic retinopathy: a two-sample Mendelian randomization analysis.
Ma L; Dong Y; Li Z; Meng J; Zhao B; Wang Q
Sci Rep; 2024 Feb; 14(1):4964. PubMed ID: 38424453
[TBL] [Abstract][Full Text] [Related]
20. BMI and plasma lipid levels with risk of proliferative diabetic retinopathy: a univariable and multivariable Mendelian randomization study.
Shu Y; Zhou Q; Shao Y; Lin H; Qu S; Han W; Lv X; Bi Y
Front Nutr; 2023; 10():1099807. PubMed ID: 37771754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
